缅北禁地

Skip to main content

Staff Profile

Dr Quentin Campbell Hewson

Associate Clinical Lecturer

Publications
  • Moreno L, Marshall LV, Pearson ADJ, Morland B, Elliott M, Campbell-Hewson Q, Makin G, Halford SER, Acton G, Ross P, Kazmi-Stokes S, Lock V, Rodriguez A, Lyons JF, Boddy AV, Griffin MJ, Yule M, Hargrave D. . Clinical Cancer Research 2015, 21(2), 267-273.
  • Iyer P, Sibal N, Chaudhari M, Wood KM, Campbell-Hewson Q. . Journal of Clinical Ultrasound 2015, 43(4), 262-264.
  • Hargrave DR, Pearson ADJ, Moreno L, Morland B, Elliott M, Makin G, Campbell-Hewson Q, Wyld PJ, Halford SER, Lock V, Lyons JF, Boddy AV, Yule M. A phase I trial of AT9283 (a selective inhibitor of Aurora kinases) given for 72 hours every 21 days via intravenous infusion in children and adolescents with relapsed and refractory solid tumours. In: JOURNAL OF CLINICAL ONCOLOGY. 2012, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA: AMER SOC CLINICAL ONCOLOGY.
  • Devdas JM, Campbell-Hewson Q, Friswell M, Gupta A, Featherstone T, Cooke A, DeKiewiet G, Hopper NW. Lateral deviation of toes requires lateral thinking. ARCHIVES OF DISEASE IN CHILDHOOD 2009, 94(1), 69-69.